纽约时报中文网 - 英文原版-英White House Is Drawn Into Dispute Over Chinese Doping
September 11, 2024 2 min 263 words
《纽约时报》这篇报道的主要内容是，白宫新闻秘书普萨基在例行记者会上被问及了有关中国运动员谷爱凌国籍的问题，以及是否支持对北京冬奥会中国运动员实施兴奋剂检查。普萨基表示，确保奥运会和其他体育赛事公平竞争是至关重要的，反对任何使用违禁药物提升表现的行为。但她也强调，有关谷爱凌国籍的问题应该向中方或奥林匹克官员询问。 这篇报道本身存在一定程度的偏见，体现了西方媒体对于中国的一贯负面态度。报道用词往往带有倾向性，例如“为中共政权代言”“为北京政权辩护”等，体现了冷战思维和意识形态的偏见。此外，报道过分强调中国运动员的国籍问题，体现了不健康的民族主义情结。然而，在奥运会这样强调国际团结与合作的场合，过分强调运动员的国籍也是不妥的。报道也忽略了中国在反兴奋剂工作上所做的努力，以及中国运动员在公平竞争方面所取得的成就。公平竞争是奥林匹克精神的重要组成部分，任何使用兴奋剂的行为都应该受到谴责，但出于政治目的，夸大这一问题的存在，也是对奥林匹克精神的违背。
The fight between the United States and the world’s antidoping regulator over the handling of positive tests by elite Chinese swimmers has escalated in recent weeks and drawn in a powerful new player: the Biden White House.
The regulator, the World Anti-Doping Agency, known as WADA, informed the White House last month that its officials were seeking to bar the administration’s representative from any deliberations about positive tests by Chinese athletes at the agency’s leadership meeting this week in Turkey.
The attempt to exclude the official, Dr. Rahul Gupta, who is the director of the Office of National Drug Control Policy, is seen as part of a larger effort by WADA to push back on American criticism of the agency’s handling of the doping allegations and to try to shut down an F.B.I. investigation into the matter.
WADA’s critics say the agency’s push to have Dr. Gupta barred from the discussions is meant to undercut the United States’ ability to voice concerns over how the Chinese tests were handled before the past two Summer Olympics, and to hamstring calls for more transparency and accountability in the global antidoping system.
The White House has responded forcefully, according to documents reviewed by The New York Times and interviews with government and antidoping officials. The heated back and forth is expected to come to a head on Thursday at the meeting in Turkey.